P D Greenberg

2.9k total citations · 1 hit paper
23 papers, 2.3k citations indexed

About

P D Greenberg is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, P D Greenberg has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 7 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in P D Greenberg's work include Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). P D Greenberg is often cited by papers focused on Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). P D Greenberg collaborates with scholars based in United States, South Africa and Canada. P D Greenberg's co-authors include SR Riddell, Martin A. Cheever, Meyers Jd, P Reusser, A Fefer, D E Kern, Stanley R. Riddell, Adam P. Geballe, Michael S. Rabin and William J. Britt and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

P D Greenberg

23 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease

1991 556 citations P Reusser, SR Riddell et al. Blood profile →

Peers

Countries citing papers authored by P D Greenberg

Since Specialization

Citations

This map shows the geographic impact of P D Greenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P D Greenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P D Greenberg more than expected).

Fields of papers citing papers by P D Greenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P D Greenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P D Greenberg. The network helps show where P D Greenberg may publish in the future.

Co-authorship network of co-authors of P D Greenberg

This figure shows the co-authorship network connecting the top 25 collaborators of P D Greenberg. A scholar is included among the top collaborators of P D Greenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P D Greenberg. P D Greenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains 2011 ·Gene Therapy ·David H. Aggen, Adam S. Chervin, Thomas M. Schmitt, Boris Engels, Jennifer D. Stone, Sarah A. Richman, Kurt H. Piepenbrink, Brian M. Baker, P D Greenberg, (unknown), David M. Kranz	42
2	Development of a novel strategy for engineering high-affinity proteins by yeast display 2006 ·Protein Engineering Design and Selection ·Sarah A. Richman, (unknown), K. Scott Weber, David L. Donermeyer, Michelle L. Dossett, P D Greenberg, Paul M. Allen, David M. Kranz	32
3	Viral dynamics of early HIV infection in neonatal macaques after oral exposure to HIV‐2₂₈₇: an animal model with implications for maternal–neonatal HIV transmission 2002 ·Journal of Medical Primatology ·Arnd M. Herz, Michael Robertson, John B. Lynch, Ann Marie Schmidt, Mark Rabin, (unknown), Michael B. Agy, David Anderson, (unknown), P D Greenberg, William R. Morton	13
4	Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure 1997 ·The Journal of Immunology ·Stephen J. Kent, P D Greenberg, (unknown), Robert E. Akridge, M J McElrath	32
5	Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals. 1994 ·PubMed ·M. Juliana McElrath, Lawrence Corey, P D Greenberg	2
6	Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis 1994 ·Blood ·(unknown), P D Greenberg, (unknown), (unknown), SR Riddell	402
7	Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis 1994 ·Blood ·(unknown), P D Greenberg, (unknown), (unknown), SR Riddell	19
8	Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. 1993 ·The Journal of Immunology ·Marc A. Gavin, (unknown), Stanley R. Riddell, P D Greenberg, (unknown)	114
9	Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8 ⁺ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington 1992 ·Human Gene Therapy ·(unknown), P D Greenberg, Robert W. Overell, (unknown), M. Jean Gilbert, Stephen D. Lupton, Jan M. Agosti, (unknown), (unknown), Lawrence Corey	65
10	Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease breakdown → 1991 ·Blood ·P Reusser, SR Riddell, Meyers Jd, P D Greenberg	556
11	Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression 1991 ·The Journal of Immunology ·Stanley R. Riddell, Michael S. Rabin, Adam P. Geballe, William J. Britt, P D Greenberg	195
12	Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells. 1990 ·PubMed ·Kirk R. Schultz, J Klarnet, David Peace, Martin A. Cheever, C Badger, Irwin D. Bernstein, P D Greenberg	19
13	Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity. 1989 ·The Journal of Immunology ·D E Kern, K H Grabstein, Kiyotaka Okuno, Robert D. Schreiber, P D Greenberg	4
14	IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes. 1988 ·The Journal of Immunology ·David Peace, D E Kern, Kirk R. Schultz, P D Greenberg, Martin A. Cheever	42
15	Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2. 1986 ·The Journal of Immunology ·John A. Thompson, David Peace, J Klarnet, D E Kern, P D Greenberg, Martin A. Cheever	84
16	Identical-Twin (Syngeneic) Marrow Transplantation for Hematologic Cancers<xref ref-type="fn" rid="FN1">1</xref><xref ref-type="fn" rid="FN2">2</xref> 1986 ·JNCI Journal of the National Cancer Institute ·A Fefer, Martin A. Cheever, P D Greenberg	52
17	Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells. 1985 ·The Journal of Experimental Medicine ·P D Greenberg, D E Kern, Martin A. Cheever	246
18	Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes. 1981 ·The Journal of Experimental Medicine ·P D Greenberg, Martin A. Cheever, A Fefer	252
19	DEFINITION OF ALIEN H‐2 DETERMINANTS ON A FRIEND LEUKAEMIA BY ANALYSIS OF ALLOREACTIVITY OF CTL FROM PRIMARY MLC 1981 ·International Journal of Immunogenetics ·P D Greenberg, Martin A. Cheever, A Fefer	3
20	Therapy of leukemia by nonimmune syngeneic spleen cells. 1980 ·The Journal of Immunology ·Martin A. Cheever, P D Greenberg, A Fefer	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact